Clinical Trial Update: Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

Phase 3 efficacy confirmation trial in Japanese patients with rheumatoid arthritis evaluating certolizumab pegol (CDP870) without methotrexate coadministration;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-08-06